CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today

CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today

Virtual Medical Event Available from the Convenience of a Computer www.CardioCareLive.com takes place entirely online Tuesday March 3 and Wednesday March 4 from 9:30 AM to 8:00 PM Eastern. Patch Adams, MD, the real physician behind the movie starring Robin Williams, is even slated to speak. To register now for free, visit cardioCareLive.com.

Needham, MA (PRWEB) March 3, 2009 -- CardioCareLive (http://www.CardioCareLive.com), the first-ever online-only conference for medical professionals who manage patients with cardiometabolic risk factors, begins today at 9:30 AM Eastern. Cardiologists, endocrinologists, primary care physicians and registered nurses can have their questions addressed live by leading experts in cardiometabolic care from the ease of a PC. This event offers live keynote presentations (http://cardiocarelive.com/en_CA/guest/app-agenda) with Q & A, peer networking and an exhibit floor, entirely online at CardioCareLive.com on Tuesday March 3 and Wednesday March 4 from 9:30 AM to 8:00 PM Eastern.

CardioCareLive features leading cardiovascular experts live via video, such as Louis Aronne, MD; Christie Ballantyne, MD; Roger Blumenthal, MD; Robert Eckel, MD; Peter Libby, MD; Laurie Mosca, MD; Richard Nesto, MD; Clyde Yancy, MD and more. Patch Adams, MD, the real physician behind the movie starring Robin Williams, is even slated to speak.

Acknowledging the busy lives of physicians, CardioCareLive offers continuing education (http://cardiocarelive.com/en_CA/guest/cme) at no cost and completely online, and all presentations will be available on-demand for ninety days after the event concludes. To view a complete list of speakers, agenda, or to register now for free, visit CardioCareLive.com.

About CardioCareLive

CardioCareLive.com, a medical conference which features "Improving Cardiometabolic Patient Outcomes" presented by Johns Hopkins Office of Continuing Medical Education, take place entirely online, enables healthcare practitioners and others interested in understanding and managing cardiometabolic risk factors to learn, connect and interact through powerful Web-based software and services.

CardioCareLive is produced, in cooperation with Johns Hopkins, by PlatformQ whose mission is to connect people, companies, organizations and associations worldwide to meet, interact and learn from leading experts and thought leaders through proven interactive tools at online events.

CardioCareLive and PlatformQ are trademarks of PlatformQ, LLC. All other trademarks or service marks are property of their respective owners.

###

Contact Information Martha Collins

PlatformQ, LLC.

http://www.CardioCareLive.com

(617) 938-6008

Sal Giliberto

PlatformQ, LLC.

http://www.CardioCareLive.com

(617) 938-6006

VisMini 2.0 Carry-On Stereo 3D Projector, Low Cost, No Silver Screen - Available Now from Valley View Tech

VisMini 2.0 Carry-On Stereo 3D Projector, Low Cost, No Silver Screen - Available Now from Valley View Tech

VisMini 2.0 Portable Stereo 3D Projector, from Valley View Tech, cutting-edge technology, lowest-price (US $13,995), highly portable and versatile, passive stereo 3D projector-pair display system - less than one-half the price/weight of competitive systems with NO silver screen needed for display.

Los Gatos, CA (PRWEB) March 3, 2009 -- Valley View Tech, a Silicon Valley-based marketing and sales firm specializing in high-quality, high-tech products for 3D visualization, virtual reality, and immersive 3D, today announced the availability of VisMini 2.0 by Visbox, Inc. VisMini is the value leader in high-quality, truly-portable (fits in an airplane overhead), passive stereoscopic 3D projectors and requires no silver screen -- no more need to carry around an additional 50-100 pounds. The system is ideal for anyone who wants the dramatic impact of stereo 3D and needs to "take stereo 3D on the road."

VisMini 2.0 weighs just 11 pounds, is approximately the size of a three-ream stack of standard paper (11.2" wide x 9" deep x 6.3" high), and is the first truly portable passive stereo 3D solution. The VisMini projector comes with a hardened Pelican™ case, enabling the user to move quickly through airports with convenient carry-on sized baggage that fits in the overhead compartment of most airplanes.

The combined weight of the VisMini Basic with hardened case, glasses, and cables is just 27 pounds. By comparison, other so called "portable" passive stereo 3D projectors cost $35,000 and up, twice the price of the VisMini, and require heavy, cumbersome "silver screens," weighing from 50-to-100+ pounds, too heavy and large to be allowed on board as carry-on luggage. VisMini, the most user friendly 3D stereo projector system available, takes minutes to set up for display on any existing screen or any light-colored wall and projects images that are flicker free for comfortable viewing with passive glasses.

Dr. Carolina Cruz-Neira, Virtual Reality pioneer and co-inventor of the CAVE system, was an early adopter of VisMini. She stated, "I am constantly asked to bring demonstrations of my projects when I travel around the world. VisMini has made it simple and easy to showcase my work outside my lab. VisMini is my personal presentation system for live demonstrations of my 3D work when I am on the road. It is easy carry-on to take with me on planes, quick to set up in most standard conference rooms, and does not require specialized screens or computers."

VisMini is a general-purpose stereo display system that can be used to display a variety of stereo 3D applications and is designed for commercial and academic use -- ranging from medical research and training to geosciences to architecture to entertainment. Any application that supports OpenGL quad-buffered stereo will work with VisMini in stereoscopic 3D mode. This includes applications such as Maya from Autodesk, Discovery Studio from Accelrys, and Second Life in stereoscopic mode. Software designed for active stereo 3D will also project from VisMini.

"The VisMini allows you to walk into any conference room and be ready to present 3D visualizations within a couple of minutes. It is the ideal portable 3D stereo presentation solution," said Paul Rajlich, Vice President, Visbox, Inc. "We are excited to be working with Valley View Tech to help expand the awareness of VisMini and the other Visbox stereo display products to a broader array of both commercial and academic customers around the world."

VisMini 2.0 Basic is available immediately from Valley View Tech for the special introductory price of US$ 13,995. VisMini Basic includes:

•    VisMini projection unit;

•    One premium and four standard pairs of glasses;

•    Video and power cable;

•    Rugged carry-on travel case.

The VisMini 2.0 Basic, including its rugged carry-on case, weighs just 27 pounds and fits in the overhead of most airplanes.

Valley View Tech offers VisMini 2.0 Complete, also available immediately, for the special introductory price of US$ 17,995. VisMini Complete includes:

•    VisMini projection unit;

•    Mobile workstation computer with NVIDIA™ Quadro FX graphics card;

•    DVI to VGA converter;

•    One premium and four standard pairs of glasses;

•    Video and power cables;

•    Rugged, check-in-size travel case to carry all of the above.

The entire VisMini Complete, with case, weighs just 47 pounds and can be taken along as checked baggage.

Both VisMini 2.0 Basic and VisMini 2.0 Complete are calibrated by, and shipped directly from Visbox and carry the Visbox standard warranty.

About Valley View Tech:

Valley View Tech, located in the Santa Cruz Mountains above Silicon Valley, markets, sells, and distributes high-quality, high-tech stereo 3D display products, specifically focused on 3D visualization, immersive 3D, and virtual reality. Valley View Tech represents Visbox' VisMini™ Portable Stereo 3D Projector Displays; Immersive 3D Displays - VisDuo™, VisBox™, and VisCube™; and High Resolution Tiled Displays - VisWall™ and VisWall-LCD™. For more information, please visit: http://www.valleyviewtech.com

Press contact:

Frances Mann-Craik

Addison Marketing

frances (at) addisonmarketing (dot) com

408-868-9577

###

Contact Information Frances Mann-Craik

Valley View Tech

http://www.valleyviewtech.com

408-868-9577

CIRM Completes Briefing Visit to Stemedica Cell Technologies

CIRM Completes Briefing Visit to Stemedica Cell Technologies

Leadership of the California Institute for Regenerative Medicine ("CIRM") completed a two part visit to Stemedica Cell Technologies, Inc. ("Stemedica") to tour its manufacturing facility, R&D lab and corporate headquarters.

San Diego, Calif. (PRWEB) March 2, 2009 -- Leadership of the California Institute for Regenerative Medicine ("CIRM") completed a two part visit to Stemedica Cell Technologies, Inc. ("Stemedica") to tour its manufacturing facility, R&D lab and corporate headquarters.

"I was glad to have the opportunity to visit Stemedica and get to know more about its leadership, plans for the future and to see first hand the assets and potential they represent to the stem cell movement in California", said Dr. Alan Trounson, President of CIRM. "We want to have strong working relationships with all sectors of California's stem cell industry, including for-profit companies like Stemedica."

Prior to Dr. Trounson's visit, Dr. Marie Csete, CIRM's Chief Scientific Officer had the opportunity to visit Stemedica's manufacturing facility and R&D laboratory. "We're delighted to see Stemedica make the effort to secure a clinical grade manufacturing license from the State of California. We believe this capability will aid numerous organizations in California and around the world in their efforts to manufacture stem cell products for clinical application", said Dr. Csete.

"We were pleased to have Dr. Trounson and Dr. Marie Csete visit our facilities and receive a briefing from our leadership", said Dr. Maynard Howe, Stemedica's Vice Chairman & CEO. "We continue to play a pivotal role in the evolution of the stem cell industry in California and believe a supportive working relationship with CIRM is an essential part of this process.

Stuart Lipton, M.D., Ph.D., Scientific Director and Senior Vice President of the Del E. Webb Center for Neuroscience, Aging and Stem Cell Research at the Burnham Institute for Medical Research, San Diego, CA, joined Dr. Trounson during his visit to Stemedica's manufacturing facility. "I was impressed with the progress that Stemedica has made on the licensing process for clinical grade allogeneic stem cell manufacturing and am excited about expanding our research relationship with the Stemedica team. Having a manufacturing resource like this in California will be a great asset to our entire research community. I anticipate that many CIRM-funded stem cell research institutions will take advantage of Stemedica's manufacturing facility that will soon become FDB (Food & Drug Board) cGMP licensed."

Dr. Nikolai Tankovich, Stemedica's President and Chief Medical Officer organized the visits for Dr. Trounson, Dr. Csete and Dr. Lipton. "We're delighted that these outstanding leaders within California's stem cell movement took the time to find out more about Stemedica and our plans to lead this industry from a manufacturing standpoint. We will continue to seek the wise counsel of CIRM in an effort to align our efforts with theirs. In addition, we are expanding our collaborative research efforts with the Burnham Institute for Medical Research and several other California stem cell research institutions", said Dr. Tankovich.

About Stemedica Technologies, Inc.:

Stemedica Cell Technologies Inc. (http://www.stemedica.com (http://www.stemedica.com)) is a specialty biopharmaceutical company that is committed to the development and manufacture of best-in-class adult stem cells for use by approved research institutions and hospitals for pre-clinical and clinical studies. Within the United States, the Company is currently developing regulatory pathways for stroke, traumatic brain injury and wound repair. Outside the United States, Stemedica provides its adult stem cells to hospitals and research centers that are conducting studies under protocols approved by the appropriate regulatory agencies. These studies are focused on the treatment of neurodegenerative disease, sight restoration and wound repair. Stemedica is based in San Diego, California.

About CIRM:

The California Institute for Regenerative Medicine (CIRM) was established in 2005 with the passage of Proposition 71, the California Stem Cell Research and Cures Act. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was overwhelmingly approved by voters, and called for the establishment of an entity to make grants and provide loans for stem cell research, research facilities, and other vital research opportunities. To date, the CIRM governing board has approved 229 research and facility grants totaling more than $614 million, making CIRM the largest source of funding for human stem cell research in the world. For more information, please visit http://www.cirm.ca.gov (http://www.cirm.ca.gov/).

Media Contact for Stemedica: Dave McGuigan at dmcguigan (at) stemedica.com.

# # #

Contact Information Dave McGuigan

Stemedica Cell Technologies Inc

http://www.stemedica.com

+1 858 658 0910

Society of American Gastrointestinal and Endoscopic Surgeons to Present the SAGES 2009 Scientific Session and Postgraduate Courses in April 2009

Society of American Gastrointestinal and Endoscopic Surgeons to Present the SAGES 2009 Scientific Session and Postgraduate Courses in April 2009

The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) will convene its 2009 Scientific Session and Postgraduate Courses in Phoenix, Arizona from April 22-25, 2009. The SAGES Annual Meeting has been the pre-eminent meeting for minimally invasive surgery for the past twenty-eight years. The meeting is expected to draw more than 2,000 surgeons, surgeons-in-training, GI assistants, nurses and other allied health professionals who are interested in minimally invasive surgery and gastrointestinal surgery. The 2009 Program Chair is L. Michael Brunt, MD, from the Washington University School of Medicine in St. Louis, Missouri.

Los Angeles, California (PRWEB) March 1, 2009 -- The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) will convene its 2009 Scientific Session and Postgraduate Courses in Phoenix, Arizona from April 22-25, 2009.

The SAGES Annual Meeting has been the pre-eminent meeting for minimally invasive surgery for the past twenty-eight years. The meeting is expected to draw more than 2,000 surgeons, surgeons-in-training, GI assistants, nurses and other allied health professionals who are interested in minimally invasive surgery and gastrointestinal surgery. The 2009 Program Chair is L. Michael Brunt, MD, from the Washington University School of Medicine in St. Louis, Missouri.

The scientific program has been carefully designed to incorporate many of the scientific and technical advances from the leading experts in the fields of general, gastrointestinal, endoscopic and minimally invasive surgery. The program begins on Wednesday, April 22, 2009 with a variety of half-day postgraduate and hands-on courses on such topics as colorectal, hernia, flexible endoscopy, endolumenal/NOTES®, bariatric, laparoscopic cholecystectomy and the Fundamentals of Laparoscopic Surgery (FLS). Wednesday also features the SAGES Education and Research Foundation Awards Luncheon, recognizing distinguished leaders for their work in minimally invasive surgery and helped to keep patient safety and MIS in the forefront. Thursday, April 23, 2009 continues with more courses on foregut and advanced laparoscopic techniques, a special Allied Health Symposium on patient safety, a Endolumenal/NOTES® Symposium, a robotics panel, a forum and luncheon for surgical educators, and the SAGES Great Presidential Debates, a session dedicated to a broad range of issues including Universal Healthcare. Both Friday and Saturday's sessions are devoted to a range of engaging panels, concurrent sessions and keynote lectures. Dr. John Cameron will be delivering the Gerald Marks Lecture, "The Surgeon as a Role Model" on Friday with Dr. Catherine DeAngelis, Editor of JAMA, delivering the Health Policy Lecture on conflict of interest on Saturday.

SAGES Exhibits, Learning Center and Posters are open Thursday through Friday with the Poster session running until Saturday, April 25th.

Since 2005 the SAGES Scientific Session and Postgraduate Courses have been a part of Surgical Spring Week, a week of surgical meetings which have included the American College of Surgeons and the American Hepato-Pancreato Biliary Association. In 2009 SAGES meets once again with the International Pediatric Endosurgery Group (IPEG), the premiere international association for physicians who perform minimally invasive surgery in children. Several joint sessions have been incorporated into both programs including the joint panel, "Urgent and Emergent Acute Case Problems in Pediatric and Adult Patients" on Friday afternoon.

More information about the annual meeting and Surgical Spring Week is posted regularly on the SAGES website, http://www.sages.org/meetings/. Interested parties may sign up for our e-newsletter by submitting an email address on the same site.

Questions should be directed to SAGES, 11300 W. Olympic Bvld., Suite 600, Los Angeles, CA 90064, Phone: 310-437-0544, Fax: 310-437-0585, Email: sagesweb (at) sages (dot) org

# # #

Contact Information Jennifer Clark

Society of American Gastrointestinal and Endoscopic Surgeons

http://www.sages.org

310-437-0554